Diminished Production of Monocyte Proinflammatory Cytokines during Human Immunodeficiency Virus Viremia Is Mediated by Type I Interferons
Open Access
- 1 December 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (23) , 11486-11497
- https://doi.org/10.1128/jvi.00324-06
Abstract
The effect of human immunodeficiency virus (HIV) infection and high-level HIV replication on the function of monocytes was investigated. HIV-positive patients had elevated levels of spontaneous production of some or all of the monocyte proinflammatory cytokines measured (interleukin-1β [IL-1β], IL-6, and tumor necrosis factor alpha [TNF-α]) compared to uninfected controls. In patients on therapy with high frequencies of monocytes producing proinflammatory cytokines, this frequency was diminished in the context of viremia during an interruption of therapy. Diminished production of proinflammatory cytokines during viremia was restored by culture with autologous CD4+ T cells or monocytes from an on-therapy time point or lipopolysaccharide (LPS). Microarray analysis demonstrated that diminished monocyte production of proinflammatory cytokines was correlated with elevated type I interferon-stimulated gene transcripts. The addition of exogenous alpha 2A interferon diminished the spontaneous production of IL-1β, IL-6, and TNF-α but did not affect responses to LPS, recapitulating the changes observed for HIV-viremic patients. These results suggest that monocyte function is diminished during high-level HIV viremia and that this effect is mediated by chronic stimulation by type I interferons. This effect on monocytes during viremia may play a role in diminished innate or adaptive immune system functions in HIV-infected patients. In addition, the restoration of these functions may also play a role in some immune reconstitution syndromes observed during initiation of therapy.Keywords
This publication has 63 references indexed in Scilit:
- Impaired Monocyte Maturation in Response to CpG Oligodeoxynucleotide Is Related to Viral RNA Levels in Human Immunodeficiency Virus Disease and Is at Least Partially Mediated by Deficiencies in Alpha/Beta Interferon Responsiveness and ProductionJournal of Virology, 2005
- Functional Genomic Analysis of the Response of HIV‐1–Infected Lymphatic Tissue to Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004
- HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative CapacityThe Journal of Experimental Medicine, 2003
- Plasma Bioavailable Interleukin‐6 Is Elevated in Human Immunodeficiency Virus–Infected Patients Who Experience Herpesvirus‐Associated Immune Restoration Disease after Start of Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2001
- Serum levels of β2-microglobulin, neopterin, TNF-α and soluble receptors of TNF-α and interleukin-2 in intravenous drug abusers according to HIV-1 status and stage of the HIV-1 infectionClinical Microbiology & Infection, 1998
- CD8+, CD38+ Lymphocyte PercentJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Increased spontaneous secretion of interleukin 6 and tumor necrosis factor alpha by peripheral blood lymphocytes of human immunodeficiency virus-infected childrenPediatric Infectious Disease, 1994
- T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort studyClinical Immunology and Immunopathology, 1989
- Acid-Labile Alpha InterferonNew England Journal of Medicine, 1983